Literature DB >> 14730617

Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.

Guillaume Page1, Guillaume Chevrel, Pierre Miossec.   

Abstract

OBJECTIVE: To clarify the involvement of dendritic cells (DCs), chemokines, and proinflammatory Th1 cytokines in the pathogenesis of the chronic muscle diseases dermatomyositis (DM) and polymyositis (PM).
METHODS: We characterized by immunohistochemistry the DC subsets and their interaction with cells producing chemokines and the Th1 cytokines interleukin-17 (IL-17) and interferon-gamma (IFNgamma). Immature and mature DCs were defined by the expression of CD1a and DC-LAMP/CD83, respectively.
RESULTS: Immature DCs were mainly detected in lymphocytic infiltrates in DM and PM muscle tissue samples. Mature DCs were detected in perivascular infiltrates and surrounded muscle fibers. IL-17-positive and IFNgamma-positive cells were also observed in perivascular infiltrates in both cases. We then focused on the expression of the CCL20/CCR6 chemokine/receptor complex, which controls immature DC migration, and on the expression of the CCL19/CCR7 and CCL21/CCR7 chemokine/receptor complexes, which control mature DC migration. CCL20 and CCR6 colocalized in lymphocytic infiltrates in DM and PM samples. CCL21 was rarely observed in DM samples and never observed in PM samples. CCL19- and CCR7-expressing cells were absent in both tissues.
CONCLUSION: The close association between CCL20/CCR6 and immature DCs suggests the contribution of CCL20 to CCR6+ immature DC homing. Detection of mature DCs in DM and PM muscle tissue samples despite the lack of CCL19 and CCR7 is evidence for a local maturation of DCs in inflammatory muscle tissue without lymphoid organ organization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730617     DOI: 10.1002/art.11428

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  45 in total

Review 1.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

2.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 3.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 4.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

5.  Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.

Authors:  M Tucci; C Quatraro; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

6.  Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles.

Authors:  M Cristina Lebre; Sarah L Jongbloed; Sander W Tas; Tom J M Smeets; Iain B McInnes; Paul P Tak
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

Review 7.  A critical role for immature muscle precursors in myositis.

Authors:  Anne Tournadre; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2013-03-12       Impact factor: 20.543

Review 8.  Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.

Authors:  Frédéric Coutant; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

Review 9.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

10.  Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.

Authors:  Geun-Tae Kim; Mi-La Cho; Young-Eun Park; Wan Hee Yoo; Jung-Hee Kim; Hye-Jwa Oh; Dae-Sung Kim; Seung-Hoon Baek; Sun-Hee Lee; Jun-Hee Lee; Ho-Youn Kim; Sung-Il Kim
Journal:  Clin Rheumatol       Date:  2009-12-02       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.